Parkside Financial Bank & Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
BC
Parkside Financial Bank & Trust's XBI Position: Q2 2025 in Review
Parkside Financial Bank & Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 12 shares — an estimated $975 sold.
Parkside Financial Bank & Trust first reported a position in XBI in Q4 2017 and held it in 29 quarters. The position peaked at $49.3K in Q2 2023. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.
- Parkside Financial Bank & Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
- Parkside Financial Bank & Trust sold 12 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $975.
- Parkside Financial Bank & Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 29 quarters.
- Parkside Financial Bank & Trust's State Street SPDR S&P Biotech ETF position peaked at $49.3K in Q2 2023.
- 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.